首页|基于肠道微生态探讨中医药治疗非酒精性脂肪性肝病的作用机制

基于肠道微生态探讨中医药治疗非酒精性脂肪性肝病的作用机制

扫码查看
非酒精性脂肪性肝病(NAFLD)是一种与肥胖、胰岛素抵抗和血脂异常相关的多系统疾病,其发病机制较为复杂.肠道菌群失调与NAFLD的发病密切相关,中医药治疗可通过调节肠道菌群及其代谢产物,改善NAFLD患者的实验室指标和临床症状.本文总结了NAFLD与肠道菌群的关系、肠道菌群失调参与NAFLD的发病机制,从肠道菌群角度探讨中医药治疗改善NAFLD的可能等,以期为NAFLD的治疗拓展新的思路.
Mechanism of action of traditional Chinese medicine in treatment of nonalcoholic fatty liver disease based on intestinal microecology
Nonalcoholic fatty liver disease(NAFLD)is a multisystem disease associated with obesity,insulin resistance,and dyslipidemia and has a complex pathogenesis.Studies have shown that gut microbiota dysbiosis is closely associated with the onset of NAFLD,and traditional Chinese medicine treatment can improve the laboratory markers and clinical symptoms of NAFLD patients by regulating intestinal microbiota and its metabolites.This article elaborates on the association between NAFLD and gut microbiota,the involvement of gut microbiota dysbiosis in the pathogenesis of NAFLD,and the possible mechanism of traditional Chinese medicine treatment in improving NAFLD from the perspective of gut microbiota,in order to provide new ideas for the treatment of NAFLD.

Non-alcoholic Fatty Liver DiseaseGut MicrobiotaTCM Therapy

杨雪、张旭、仙晋、谭奇纹、于慧娟

展开 >

山东中医药大学针灸推拿学院,济南 250014

山东中医药大学附属医院治未病中心,济南 250014

非酒精性脂肪性肝病 肠道菌群 中医疗法

山东中医药大学重点学科项目山东中医药大学附属医院朝阳人才项目

2024

临床肝胆病杂志
吉林大学

临床肝胆病杂志

CSTPCD北大核心
影响因子:1.428
ISSN:1001-5256
年,卷(期):2024.40(4)
  • 58